Oluwadi New Org. · JULY 28, 2026 · Blog ·
Oluwadi

Investigating the Overlooked

Investors Companies

Biotech / Pharma

Personalis

Biotech / Pharma
[subscription] Tempus, healthcare AI company, agreed to acquire Personalis, provider of personalized cancer management testing, for $1.25B.. Personalis. Fwd: AI's true cost
Founded
Region
Investors
People